authors
- Salloway, S
- Hernandez, C
- Crans, G
- Liang, E
- Quinn, G
- Bairu, M
- Pastrak, A
- Cedarbaum, J M
- Reisa Sperling, MD
- Keren, R
- Porsteinsson, A P
- van Dyck, C H
- Tariot, P N
- Gilman, S
- Arnold, D
- Abushakra, S
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2011
published in
- Neurology Journal
has subject area
- Administration, Oral
- Aged
- Aged, 80 and over
- Alzheimer Disease
- Amyloid beta-Peptides
- Apolipoprotein E4
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Follow-Up Studies
- Humans
- Inositol
- Magnetic Resonance Imaging
- Male
- Mental Status Schedule
- Middle Aged
- Peptide Fragments
- Platelet Aggregation Inhibitors
- Time Factors
- Treatment Outcome